jasmine lee, tan jen ern, wong sau wei. (2025). aetiology and treatment outcome in infantile epileptic spasms syndrome: a retrospective study from a tertiary paediatric neurology centre. - the 24th annual meeting of the infantile seizure society (iss), in conjunction with the 33rd malaysian society of neurosciences (msn) annual scientific meeting, the 13th malaysian paediatric neurology update meeting, and the 7th brains | bnc research and . .
fook-choe cheah, sharifah azween syed omar, jasmine lee, zheng jiet ang, anu ratha gopal, wan nurulhuda wan md zin, beng kwang ng, shu-chuan chiang, yin-hsiu chien. (2025). umbilical cord blood sampling for newborn screening of pompe disease and the detection of a novel pathogenic variant and pseudodeficiency variants in an asian population. - international journal of neonatal screening. 1 - 16.
cheah fc, syed omar sa, lee j, md zin wn, ng bk, chiang sc, chien ys, borhanuddin b. (2024). a pilot study to evaluate the use of umbilical cord blood in dried blood spot test for newborn screening of infantile-onset pompe disease. - the 23rd congress of the federation of the asia and oceania perinatal societies. .
jasmine lee, michelle min-fang yee , boekhtiar borhanuddin, wan nurulhuda wan md zin, sharifah azween syed omar, shu-chuan chiang, yin-hsiu chien, fook-choe cheah. (2023). exploration of the use of umbilical cord blood for newborn screening of infantile-onset pompe disease on dried blood spot testing. - strengthening perinatal care: back to basics. 29th regional perinatal society malaysia congress 2023. 129.
syed omar sa, merasa s, lee j, md zin wn, anu ratha g, ng bk, chiang sc, chien ys, cheah fc. (2023). evaluate of the use of umbilical cord blood sampling for the pilot study of newborn screening (nbs) on pompe disease in a university teaching hospital in malaysia.. - 14th international congress of human genetics (ichg2023). 647.
fook-choe cheah, sharifah azween syed omar, jasmine lee, zheng jiet ang, anu ratha gopal, wan nurulhuda wan md zin, beng kwang ng, shu-chuan chiang, yin-hsiu chien. (2025). umbilical cord blood sampling for newborn screening of pompe disease and the detection of a novel pathogenic variant and pseudodeficiency variants in an asian population. - international journal of neonatal screening. 1 - 16.
jasmine lee, tan jen ern, wong sau wei. (2025). aetiology and treatment outcome in infantile epileptic spasms syndrome: a retrospective study from a tertiary paediatric neurology centre. - the 24th annual meeting of the infantile seizure society (iss), in conjunction with the 33rd malaysian society of neurosciences (msn) annual scientific meeting, the 13th malaysian paediatric neurology update meeting, and the 7th brains | bnc research and . .
cheah fc, syed omar sa, lee j, md zin wn, ng bk, chiang sc, chien ys, borhanuddin b. (2024). a pilot study to evaluate the use of umbilical cord blood in dried blood spot test for newborn screening of infantile-onset pompe disease. - the 23rd congress of the federation of the asia and oceania perinatal societies. .
syed omar sa, merasa s, lee j, md zin wn, anu ratha g, ng bk, chiang sc, chien ys, cheah fc. (2023). evaluate of the use of umbilical cord blood sampling for the pilot study of newborn screening (nbs) on pompe disease in a university teaching hospital in malaysia.. - 14th international congress of human genetics (ichg2023). 647.
jasmine lee, michelle min-fang yee , boekhtiar borhanuddin, wan nurulhuda wan md zin, sharifah azween syed omar, shu-chuan chiang, yin-hsiu chien, fook-choe cheah. (2023). exploration of the use of umbilical cord blood for newborn screening of infantile-onset pompe disease on dried blood spot testing. - strengthening perinatal care: back to basics. 29th regional perinatal society malaysia congress 2023. 129.
jasmine lee, tow-swan chiam, fook-choe cheah. (2021). non-invasive cardiac output monitoring in preterm neonates using electrical cardiometry - a pilot study. - 27th regional annual congress of the perinatal society of malaysia. 6.
| Geran / Grant | Kolaborator / Collaborator | Status |
|---|---|---|
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF MAVORIXAFOR IN PARTICIPANTS WITH CONGENITAL AND ACQUIRED PRIMARY AUTOIMMUNE AND IDIOPATHIC CHRONIC NEUTROPENIC DISORDERS WHO ARE EXPERIENCING RECURRENT AND/OR SERIOUS INFECTIONS | x4 pharmaceuticals, inc., | 57.2% (2024-07-25 sehingga 2026-10-24) |